Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of Sarepta Therapeutics Inc (NASDAQ: SRPT) was $40.05 for the day, up 0.15% from the previous closing price of $39.99. In other words, the price has increased by $0.15 from its previous closing price. On the day, 8.38 million shares were traded.
Ratios:
Our analysis of SRPT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.46 and its Current Ratio is at 4.02. In the meantime, Its Debt-to-Equity ratio is 1.18 whereas as Long-Term Debt/Eq ratio is at 1.18.
On April 11, 2025, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $115.
H.C. Wainwright Upgraded its Sell to Neutral on April 02, 2025, while the target price for the stock was maintained at $75.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 12 ’25 when Nicaise Claude sold 2,491 shares for $99.64 per share. The transaction valued at 248,203 led to the insider holds 27,812 shares of the business.
Nicaise Claude bought 2,491 shares of SRPT for $248,226 on Mar 12 ’25. On Dec 12 ’24, another insider, Wigzell Hans Lennart Rudolf, who serves as the Director of the company, sold 10,500 shares for $124.84 each. As a result, the insider received 1,310,820 and left with 22,840 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.76 while its Price-to-Book (P/B) ratio in mrq is 3.44.
Stock Price History:
Over the past 52 weeks, SRPT has reached a high of $173.25, while it has fallen to a 52-week low of $34.10. The 50-Day Moving Average of the stock is -32.45%, while the 200-Day Moving Average is calculated to be -62.37%.
Shares Statistics:
A total of 98.25M shares are outstanding, with a floating share count of 93.39M. Insiders hold about 4.98% of the company’s shares, while institutions hold 90.36% stake in the company.
